This site requires JavaScript and cookies to be enabled.

Busy Philipps’ ADHD story

Actor, author, mother of two, including a daughter with ADHD—all while living with ADHD herself. Qelbree helps Busy manage symptoms as she blazes a new path for women impacted by ADHD.

Busy Philipps is a real Qelbree patient and compensated ambassador.

Why women with ADHD go undiagnosed and untreated

Busy Philipps’ Story: The Journey to ADHD Diagnosis

It wasn’t until her daughter was diagnosed that Busy discovered she’s been living with ADHD her whole life.

It took most of her life for Busy Philipps to figure out she has ADHD and get the help she needs to manage symptoms. Now she’s using her platform to speak out for other women and mothers like her.

As Busy says, “every woman deserves to feel seen and supported in their ADHD journey.” Yet far too many women living with ADHD go undiagnosed. Busy is working hard to change that by sharing her struggles, her diagnosis experience—and her successful treatment with Qelbree.

A long path to ADHD diagnosis and treatment with Qelbree

From Misrepresented to Ms. Represented: Busy Philipps’ Journey

As an actor, author, and always-on mom, Busy is flipping the script for women experiencing ADHD.

Before Busy Philipps became a famous actor, author, and podcast star, she was a young girl struggling to focus at school and finish chores around the house. Homework buried in her backpack here. A pile of unfinished craft projects there.

The challenges of managing tasks and organizing work and activities followed Busy into adulthood. Yet it wasn’t until her daughter faced similar struggles—and was diagnosed with ADHD—that Busy realized she had the very same obstacles to overcome.

Once Busy’s healthcare provider diagnosed her with ADHD and prescribed non-stimulant Qelbree to address her symptoms, her ADHD improved at home and work. Best of all, she’s now sharing her experiences about ADHD, using her platform to speak out and help other women speak up.

Advocating for ADHD awareness

ADHD does not discriminate, yet girls and women are historically underdiagnosed. Busy is bringing that challenge to light by sharing her ADHD story and raising awareness of the signs and symptoms—so more women get the support they need.
I want women who might be experiencing ADHD symptoms to talk to their doctors. ADHD isn’t something you just have to deal with.”
Busy Philipps

Actor, author, and parent with ADHD

Paid spokesperson for Qelbree

See more ADHD stories

See the difference Qelbree is making in helping real people manage their ADHD.
Explore stories

Share your story

Share your experience of navigating ADHD with Qelbree.
Share your story

ADHD and gender

Did you know that ADHD can look different in women and men?
Explore the differences

Connect with the Qelbree community

Follow Qelbree on social media for updates.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.